Selected Recent Publications
Original articles
Ota S, Zhou ZQ, Keene DR, Knoepfler P, Hurlin PJ. Activities of N-Myc in the developing limb link control of skeletal size with digit separation. Development. 2007 Apr;134(8):1583-92. Epub 2007 Mar 14. PMID 17360777 [PubMed - indexed for MEDLINE]
Dezfouli S, Baake A, Huang J, Wynshaw-Boris A., Hurlin PJ. Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells. Mol. Cell Biol. 2006 Mar;26(6):2080-92. PMID: 16507988 [PubMed - indexed for MEDLINE].
Hooker CW, Hurlin PJ. Of Myc and Mnt. J Cell Sci. 2006 Jan 15;119(Pt 2):208-16. Review.
Walker W., Zhou ZQ, Ota S, Wynshaw-Boris A., Hurlin PJ. Mnt-Max to Myc-Max complex switching regulates cell cycle entry. J Cell Biol. 2005 May 9;169(3):405-13. Epub 2005 May 2. PMID 15866886 [PubMed - indexed for MEDLINE].
Hurlin PJ, Zhou ZQ, Toyo-oka K, Ota S, Walker WL, Hirostune S, Wynshaw-Boris A. Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. EMBO J. 2003 Sep 15; 22(18):4584-96. PMID: 12970171
Carlson H, Ota S, Song Y, Chen Y, Hurlin PJ. Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation. Oncogene. 2002 May 30; 21(24): 3827-35. PMID: 12032820
Hurlin PJ, Steingrimsson E, Copeland NG, Jenkins NA, Eisenman RN. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. EMBO J. 1999 Dec 15; 18(24): 7019-28. Erratum in: EMBO J. 2000 Jul 17; 19(14): 3841. PMID: 10601024
oratory